Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2025 investor ...

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” first quarter 2025 investor letter.

The CFX Opus Real-Time PCR System offers the reliability you depend on from Bio-Rad with improved thermal performance and an intuitive interface for your lab. Maximum ramp rate, °C/sec CFX Opus 96 ...

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

"By identifying those who test positive for the virus, individuals can be quarantined and receive treatment more quickly, helping to contain the spread of this disease." The CFX96 Dx Real-Time System ...

The renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $9.57 billion. Bio-Rad’s earnings surpassed estimates in ...

--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2025 ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Foresight™ Pro 45 cm inner diameter (ID) ...

installing Bio-Rad products and related equipment, training customers on the installation and the use of Bio-Rad products, and delivering Bio-Rad products.” The commission rates were approved by ...